Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)
$6.9100
-0.3500 ( -1.99% ) 8.3M
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Market Data
Open
$6.9100
Previous close
$7.2600
Volume
8.3M
Market cap
$2.73B
Day range
$6.7860 - $7.4690
52 week range
$5.6000 - $15.7400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 76 | Nov 06, 2024 |
8-k | 8K-related | 106 | Nov 06, 2024 |
8-k | 8K-related | 14 | Nov 06, 2024 |
4 | Insider transactions | 1 | Oct 31, 2024 |
4 | Insider transactions | 1 | Oct 28, 2024 |
4 | Insider transactions | 1 | Oct 17, 2024 |
4 | Insider transactions | 1 | Oct 10, 2024 |
4 | Insider transactions | 1 | Oct 04, 2024 |
4 | Insider transactions | 1 | Oct 04, 2024 |
4 | Insider transactions | 1 | Oct 04, 2024 |